Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-31T20:56:19.198Z Has data issue: false hasContentIssue false
  • English
  • Français

Fifty Cases of Epilepsy Treated with “Tridione.”

Published online by Cambridge University Press:  08 February 2018

J. Hoenig
J. Hoenig*
Affiliation:
Bethlem Royal Hospital and the Maudsley Hospital, London
Get access Rights & Permissions [Opens in a new window]

Extract

Tridione is established as by far the most powerful drug in the control of petit mal. Many of its clinical aspects, therapeutic as well as toxic, are as yet not clear. In spite of this there is a remarkable absence of reports on the use of it in controlled clinical experiments.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 97 , Issue 407 , April 1951 , pp. 362 - 375
Copyright
Copyright © Royal College of Psychiatrists, 1951 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bloom, N., Lynch, J. B., and Brick, H.—(1948), J. Amer. Med. Ass., 138, 498.Google Scholar
Braithwaite, R. F. (1948), Brit. Med. J., 3 January, p. 14.Google Scholar
Briggs, , Nixon, J., and Emery, J. L. (1949), Lancet, 8 January, p. 59.Google Scholar
Butter, A. J. M. (1948), Brit. Med. J., 3 January, p. 13.Google Scholar
Campbell, Dan H. (1942), J. Infect. Dis., 71, 270.Google Scholar
Idem (1943). Ibid., 72, 42.Google Scholar
Carroll, F. D. (1945), Amer. J. Ophthal., 28, 373.Google Scholar
Davies, and Lennox, (1947), Epilepsy. New York, December, p. 423.Google Scholar
De Jong, R. N. (1946), J. Amer. Med. Ass., 130, 565–7.Google Scholar
Idem (1946), Amer. J. Psychiat., 103, 162.Google Scholar
Everett, G. M., and Richards, R. K. (1944), J. Pharm. Exper. Ther., 81, 4, 402–407.Google Scholar
Forster, T. W., Watson, J. W., and Neumark, E. (1949), Lancet, 26 Mar., p. 517.Google Scholar
Frank, C. W., and Holland, J. F. (1948), J. Amer. Med. Ass., 138, 1148.CrossRefGoogle Scholar
Goodman, L., and Manuel, C. (1945), Federation Proc., March, 4, 102.Google Scholar
Greaves, R. J. (1946), J. Amer. Med. Ass., 132, 44.Google Scholar
Hall, E. P. (1948), J. Ment. Sci., 397, 733.Google Scholar
Harrison, F. F., Johnson, R. D., and Ayer, D. (1946), J. Amer. Med. Ass., 132, 12–13.Google Scholar
Hoenig, J. (1949), Paper read at the International League against Epilepsy.Google Scholar
Keren, (1948), Pharm. J., January, p. 77.Google Scholar
Lancet (1947), ii, 476.Google Scholar
Lennox, W. G. (1945), J. Amer. Med. Ass., 129, 1069–73.Google Scholar
Idem (1945), Med. Clin. North Amer., 29, 1114.Google Scholar
Idem (1946), J. Pediat., 29, 356.Google Scholar
Idem (1946), Amer. J. Psychiat., 103, 159–61.Google Scholar
Idem (1947), J. Amer. Med. Ass., 134, 138–43.Google Scholar
Mackay, R. P., and Gottstein, W. K. (1946), Ibid., 132, 13–16.Google Scholar
Nattrass, F. J. (1949), Brit. Med. J., 1 January, p. 1.Google Scholar
Idem (1949), Ibid., 8 January, p. 43.Google Scholar
Richards, R. K. (1946), J. Lab. Clin. Med., 31, 1330–6.Google Scholar
Idem and Perlstein, M. A. (1946), Arch. Neurol. Psychiat., 55, 164.Google Scholar
Robinson, L. J. (1947), J. Nerv. Ment. Dis., 105–6, 661–665.Google Scholar
Thorne, F. C. (1945), Psychiat. Quart., 19, 686.Google Scholar
Whitty, C. W. M. (1949), Lancet, i, 625.Google Scholar
Young, C. J. (1949), Brit. Med. J., 30 July, p. 261.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.